Everolimus Reduces Weight Gain in Liver Transplant Recipients – Drug Discovery & Development

This was originally published on this site


Drug Discovery & Development

Drug Discovery & Development
Researchers from the Intermountain Medical Center Transplant Program found that liver transplant patients taking everolimus (Afinitor) gained less weight – and kept it off at one and two years after starting the drug—than patients taking tacrolimus, … 

https://www.dddmag.com/article/2017/05/everolimus-reduces-weight-gain-liver-transplant-recipients

Leave a Reply